InvestorsHub Logo
Followers 97
Posts 4811
Boards Moderated 0
Alias Born 02/07/2021

Re: None

Sunday, 02/21/2021 11:47:22 PM

Sunday, February 21, 2021 11:47:22 PM

Post# of 700553
Why would CRL pay 900 million for a firm that advertises failed trials on their website?

"Our experience in the development and manufacturing of autologous and allogeneic cellular immunotherapies is unparalleled. Cognate’s largest personalized cellular immunotherapy production to-date was for an autologous dendritic cell vaccine product and associated placebo that was used in a large phase III clinical trial. The starting materials (tumor and leukapheresis) and final product came from and shipped to up to 86 clinical sites across the US, Canada, Germany, and the UK."


https://www.cognatebioservices.com/cellular_immunotherapy





 
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News